查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040550

藥物釋放型支架市場規模、佔有率和趨勢分析報告：按塗層類型、最終用途、地區和細分市場預測（2026-2033 年）

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Type of Coating, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

藥物釋放型支架的市場規模與趨勢：

全球藥物釋放型支架市場預計在 2025 年達到 40 億美元，預計到 2033 年將達到 67 億美元。

預計2026年至2033年，該市場將以6.7%的複合年成長率成長。市場成長的主要促進因素是心血管疾病（CVD）盛行率的上升，而心血管疾病盛行率上升的原因包括肥胖、高血壓、糖尿病、老化、缺乏運動和不健康飲食等。 2024年10月，美國疾病管制與預防中心（CDC）報告稱，2023年美國共有919,032人死於心血管疾病，其中371,506人死於冠狀動脈疾病。約六分之一的心血管疾病死亡病例發生在65歲以下的成年人中，全國約有805,000例心肌梗塞，其中605,000例為首次發病。

與心血管疾病盛行率增加相關的風險因素

心血管疾病（CVD）盛行率的上升是推動市場發展的主要因素。冠狀動脈疾病、心臟衰竭和周邊動脈疾病病例的增加主要受肥胖、糖尿病、高血壓和缺乏運動等生活方式相關風​​險因素的影響。隨著全球人口老化，對支架置入術、血管成形術和導管介入治療等介入療法的需求持續成長。 2025年12月，美國疾病管制與預防中心（CDC）發布了2024年美國各州和地區的成人肥胖盛行率數據。肥胖的定義是體重指數（BMI）≥30 kg/m²，它會增加心臟病、糖尿病和某些癌症等慢性疾病的風險。肥胖盛行率在25%至40%以上，凸顯了製定針對全體族群的預防和治療策略的緊迫性。

經經皮冠狀動脈介入治療（PCI）例數增加。

經皮冠狀動脈介入治療（PCI）廣泛用於治療冠狀動脈疾病，恢復狹窄或阻塞的冠狀動脈血流。包括冠狀動脈疾病和急性冠狀動脈症候群在內的心血管疾病盛行率不斷上升，導致需要介入治療的患者數量增加。高血壓、糖尿病和肥胖等危險因子的增加也加劇了對此手術的需求。在2025年5月舉行的SCAI科學年會上，分析了2020年至2022年間408,060例門診PCI手術，其中1.8%在門診手術中心進行，98.2%在醫院門診部進行。儘管門診手術中心的PCI手術率上升至每萬人年0.87例，但30天內的不利事件（包括死亡、中風和出血）發生率仍低於2%。

目錄

第1章：調查方法和範圍

第2章：藥物釋放型支架市場：執行摘要

  • 市場展望
  • 細分市場預測
  • 競爭考察

第3章：藥物釋放型支架市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 全球藥物釋放型支架：市場分析工具
  • 各國市場促進因素分析
  • 市場進入吸引力評估

第4章：藥物釋放型支架市場：按塗層類型分類的細分市場分析（銷售收入：單位，銷售量：千件，2021-2033 年）

  • 按塗層類型分類的市場佔有率分析（2025 年和 2033 年）
  • 全球藥物釋放型支架市場：按塗層類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
    • 聚合物基塗料
    • 無聚合物塗層

第5章：藥物釋放型支架市場區隔分析：依最終用途分類，2021-2033年

  • 按最終用途分類的市場佔有率分析（2025 年和 2033 年）
  • 全球藥物釋放型支架市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
    • 醫院
    • 專科心血管中心
    • 門診手術中心（ASC）

第6章：藥物釋放型支架市場：區域細分分析（銷售收入：單位，銷售量：千件，2021-2033 年）

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 藥物釋放型支架的區域市佔率（2025 年和 2033 年）：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲藥物釋放型支架市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 印尼
    • 馬來西亞
    • 越南
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類（主要創新者、市場領導、新興企業）
  • 2025年公司市場分析
  • 2025/2026 年企業市場占有率分析（%）
  • 公司簡介
    • Boston Scientific Corporation
    • Medtronic
    • Abbott
    • Teleflex Incorporated（BIOTRONIK）
    • Terumo Corporation
    • B. Braun SE
    • Translumina
    • MicroPort Scientific Corporation
    • Biosensors International Group, Ltd
    • Lepu Medical
    • iVascular SLU
    • SMT
    • Meril Life Sciences Pvt. Ltd.
    • Concept Medical
    • Cardionovum GmbH
Product Code: 978-1-68038-999-9

Drug Eluting Stent Market Size & Trends:

The global drug eluting stent market size was estimated at USD 4.0 billion in 2025 and is projected to reach USD 6.7 billion by 2033, growing at a CAGR of 6.7% from 2026 to 2033. Market growth is primarily driven by the rising CVD prevalence, fueled by obesity, hypertension, diabetes, aging populations, sedentary lifestyles, and unhealthy diets. In October 2024, the CDC reported 919,032 deaths in the U.S. from cardiovascular disease in 2023, with coronary heart disease causing 371,506 deaths. About 1 in 6 CVD deaths occurred in adults under 65, and approximately 805,000 heart attacks happened nationwide, including 605,000 first-time events.

Rising Prevalence of Cardiovascular Diseases and Associated Risk Factors

The rising prevalence of cardiovascular diseases (CVDs) is a primary driver of the market. Increasing cases of coronary artery disease, heart failure, and peripheral artery disease are largely driven by lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behavior. As the global population ages, the demand for interventional procedures such as stenting, angioplasty, and catheter-based therapies continues to grow. In December 2025, the CDC released the 2024 adult obesity prevalence data for all U.S. states and territories. Obesity, defined as a BMI >=30 kg/m2, increases the risk of chronic diseases such as heart disease, diabetes, and certain cancers. Rates ranged from 25% to over 40%, highlighting the urgent need for prevention and treatment strategies across the population.

Increasing Volume of Percutaneous Coronary Intervention (PCI) Procedures

PCI is widely used to treat coronary artery disease and restore blood flow in narrowed or blocked coronary arteries. The increasing prevalence of cardiovascular diseases, including coronary artery disease and acute coronary syndromes, is raising the number of patients requiring interventional treatment. Higher incidence of risk factors such as hypertension, diabetes, and obesity further contributes to procedural demand. In May 2025, the SCAI Scientific Sessions reported that 408,060 outpatient PCI procedures (2020-2022) were analyzed, with 1.8% performed in ambulatory surgery centers and 98.2% in hospital outpatient departments. PCI use in ASCs rose to 0.87 per 10,000 person years, and 30 day adverse events, including mortality, stroke, and bleeding, remained below 2%.

Global Drug Eluting Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global drug eluting stents market report based on type of coating, end use, and region:

  • Type of Coating Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Polymer-based Coating
    • Non-biodegradable Polymers
    • Biodegradable Polymers
  • Polymer-free Coating
    • Micro porous Surface
    • Micro structured Surface
    • Slotted tubular Surface
    • Nanoporous Surface
  • End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Cardiac/Vascular Centers
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
    • Indonesia
    • Malaysia
    • Vietnam
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Drug Eluting Stent Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type of Coating Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Eluting Stent Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
  • 3.3. Global Drug Eluting Stents: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Force Analysis
    • 3.3.2. PESTLE Analysis
  • 3.4. Country-Level Market Driver Mapping
  • 3.5. Market Entry Attractiveness Assessment

Chapter 4. Drug Eluting Stent Market Segment Analysis, By Type of Coating (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • 4.1. Definition and Scope
  • 4.2. Type of Coating Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Drug Eluting Stents Market By Type of Coating Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 4.5.1. Polymer-based Coating
      • 4.5.1.1. Polymer-based Coating Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.1.2. Polymer-based Coating Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.1.2.1. Non-biodegradable Polymers
          • 4.5.1.2.1.1. Non-biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.1.2.1.2. Non-biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.1.2.2. Biodegradable Polymers
          • 4.5.1.2.2.1. Biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.1.2.2.2. Biodegradable Polymers Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 4.5.2. Polymer-free Coating
      • 4.5.2.1. Polymer-free Coating Market Estimates and Forecasts 2021 To 2033 (USD Million)
      • 4.5.2.2. Polymer-free Coating Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.1. Micro Porous Surface
          • 4.5.2.2.1.1. Micro Porous Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.1.2. Micro Porous Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.2. Micro Structured Surface
          • 4.5.2.2.2.1. Micro Structured Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.2.2. Micro Structured Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.3. Slotted Tubular Surface
          • 4.5.2.2.3.1. Slotted Tubular Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.3.2. Slotted Tubular Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
        • 4.5.2.2.4. Nanoporous Surface
          • 4.5.2.2.4.1. Nanoporous Surface Market Estimates and Forecasts 2021 To 2033 (USD Million)
          • 4.5.2.2.4.2. Nanoporous Surface Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 5. Drug Eluting Stent Market Segment Analysis, By End Use 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Drug Eluting Stents Market By End Use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
    • 5.5.1. Hospitals
      • 5.5.1.1. Hospitals Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.2. Specialty Cardiac/Vascular Centers
      • 5.5.2.1. Specialty Cardiac/Vascular Centers Market Estimates and Forecasts 2021 To 2033 (USD Million)
    • 5.5.3. Ambulatory Surgical Centers (ASCs)
      • 5.5.3.1. Ambulatory Surgical Centers (ASCs) Market Estimates and Forecasts 2021 To 2033 (USD Million)

Chapter 6. Drug Eluting Stent Market Segment Analysis, By Region, (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Drug Eluting Stents Market Share by Region, 2025 & 2033:
  • 6.5. North America
    • 6.5.1. North America Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. U.S. Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.2.5. U.S. Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Canada Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.3.5. Canada Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Canada Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.5.4.5. Canada Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.6. Europe
    • 6.6.1. Europe Drug Eluting Stents Market, 2021 To 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. UK Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.2.5. UK Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Germany Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.3.5. Germany Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. France Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.4.5. France Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Italy Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.5.5. Italy Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Spain Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.6.5. Spain Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Denmark Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.7.5. Denmark Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Sweden Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.8.5. Sweden Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Norway Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.6.9.5. Norway Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.7. Asia Pacific
    • 6.7.1. China
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory Framework
      • 6.7.1.4. China Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.1.5. China Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Japan Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.2.5. Japan Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. India Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.3.5. India Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Australia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.4.5. Australia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. South Korea Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.5.5. South Korea Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Thailand Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.6.5. Thailand Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.7. Indonesia
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Indonesia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.7.5. Indonesia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.8. Malaysia
      • 6.7.8.1. Key Country Dynamics
      • 6.7.8.2. Competitive Scenario
      • 6.7.8.3. Regulatory Framework
      • 6.7.8.4. Malaysia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.8.5. Malaysia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.7.9. Vietnam
      • 6.7.9.1. Key Country Dynamics
      • 6.7.9.2. Competitive Scenario
      • 6.7.9.3. Regulatory Framework
      • 6.7.9.4. Vietnam Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.7.9.5. Vietnam Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.8. Latin America
    • 6.8.1. Latin America Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Brazil Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.2.5. Brazil Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.3. Argentina
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Argentina Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.3.5. Argentina Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.4. Colombia
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Colombia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.4.5. Colombia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.8.5. Chile
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Chile Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.8.5.5. Chile Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
  • 6.9. MEA
    • 6.9.1. MEA Drug Eluting Stents Market, 2021 - 2033 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. South Africa Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.2.5. South Africa Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Saudi Arabia Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.3.5. Saudi Arabia Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.4. UAE
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. UAE Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.4.5. UAE Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Kuwait Drug Eluting Stents Market, 2021 To 2033 (USD Million)
      • 6.9.5.5. Kuwait Drug Eluting Stents Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In Thousand Units)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization (Key innovators, market leaders, emerging players)
  • 7.3. Company Market Position Analysis, 2025
  • 7.4. Company Market Share Analysis, 2025/2026 (%)
  • 7.5. Company Profiles
    • 7.5.1. Boston Scientific Corporation
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Medtronic
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Abbott
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Teleflex Incorporated (BIOTRONIK)
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Terumo Corporation
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. B. Braun SE
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Translumina
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. MicroPort Scientific Corporation
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Biosensors International Group, Ltd
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Lepu Medical
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
    • 7.5.11. iVascular S.L.U.
      • 7.5.11.1. Company Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic Initiatives
    • 7.5.12. SMT
      • 7.5.12.1. Company Overview
      • 7.5.12.2. Financial Performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic Initiatives
    • 7.5.13. Meril Life Sciences Pvt. Ltd.
      • 7.5.13.1. Company Overview
      • 7.5.13.2. Financial Performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic Initiatives
    • 7.5.14. Concept Medical
      • 7.5.14.1. Company Overview
      • 7.5.14.2. Financial Performance
      • 7.5.14.3. Product Benchmarking
      • 7.5.14.4. Strategic Initiatives
    • 7.5.15. Cardionovum GmbH
      • 7.5.15.1. Company Overview
      • 7.5.15.2. Financial Performance
      • 7.5.15.3. Product Benchmarking
      • 7.5.15.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 North America Drug Eluting Stents Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 North America Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 5 North America Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 6 North America Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 8 U.S. Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 9 U.S. Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 Canada Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 11 Canada Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 12 Canada Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 14 Mexico Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 15 Mexico Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Europe Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 17 Europe Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 18 Europe Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 19 Europe Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 20 UK Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 21 UK Drug Eluting Stents Market, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 22 UK Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 24 Germany Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 25 Germany Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 France Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 27 France Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 28 France Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 Italy Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 30 Italy Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 31 Italy Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Spain Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 33 Spain Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 34 Spain Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 35 Denmark Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 36 Denmark Drug Eluting Stents Market Estimates and, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 37 Denmark Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Sweden Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 39 Sweden Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 40 Sweden Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Norway Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 42 Norway Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 43 Norway Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 47 Asia Pacific Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 48 China Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 49 China Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 50 China Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 51 Japan Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 52 Japan Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 53 Japan Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 India Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 55 India Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 56 India Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 Australia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 58 Australia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 59 Australia Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 60 South Korea Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 61 South Korea Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 62 South Korea Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Thailand Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 64 Thailand Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 65 Thailand Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Indonesia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 67 Indonesia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 68 Indonesia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Malaysia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 70 Malaysia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 71 Malaysia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72 Vietnam Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 73 Vietnam Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 74 Vietnam Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 Latin America Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 76 Latin America Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 77 Latin America Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 78 Latin America Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Brazil Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 80 Brazil Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 81 Brazil Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 82 Argentina Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 83 Argentina Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 84 Argentina Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 Colombia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 86 Colombia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 87 Colombia Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 Chile Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 89 Chile Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 90 Chile Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 MEA Drug Eluting Stents Market, Region, 2021 - 2033 (USD Million)
  • Table 92 MEA Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 93 MEA Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 94 MEA Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 95 South Africa Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 96 South Africa Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 97 South Africa Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 98 Saudi Arabia Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 99 Saudi Arabia Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 100 Saudi Arabia Drug Eluting Stents Market, By End Use 2021 - 2033 (USD Million)
  • Table 101 UAE Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 102 UAE Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 103 UAE Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Kuwait Drug Eluting Stents Market, By Type of Coating, 2021 - 2033 (USD Million)
  • Table 105 Kuwait Drug Eluting Stents Market Estimates and Forecasts, By Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
  • Table 106 Kuwait Drug Eluting Stents Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value-Chain-Based Sizing & Forecasting
  • Fig. 6 QFD Modeling For Market Share Assessment
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Drug Eluting Stents Market: Market Outlook
  • Fig. 9 Drug Eluting Stents Competitive Insights
  • Fig. 10 Parent Market Outlook
  • Fig. 11 Ancillary Market Outlook
  • Fig. 12 Global Drug Eluting Stents Market Driver Impact
  • Fig. 13 Global Drug Eluting Stents Market Restraint Impact
  • Fig. 14 Porter's Five Force's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Drug Eluting Stents Market: Type of Coating Movement Analysis
  • Fig. 17 Drug Eluting Stents Market: Type of Coating Outlook and Key Takeaways
  • Fig. 18 Polymer-based Coating Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 19 Non-biodegradable Polymers Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 20 Biodegradable Polymers Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 21 Polymer-free Coating Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 22 Micro Porous Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 23 Micro Structured Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 24 Slotted Tubular Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 25 Nanoporous Surface Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 26 Drug Eluting Stents Market: End Use Movement Analysis
  • Fig. 27 Drug Eluting Stents Market: End Use Outlook and Key Takeaways
  • Fig. 28 Hospitals Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Specialty Cardiac/Vascular Centers Market Estimates and Forecast, 2021 - 2033
  • Fig. 30 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2021 - 2033
  • Fig. 31 Global Drug Eluting Stents Market: Regional Movement Analysis
  • Fig. 32 Global Drug Eluting Stents Market: Regional Outlook and Key Takeaways
  • Fig. 33 North America Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 34 Key Country Dynamics
  • Fig. 35 U.S. Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 36 Key Country Dynamics
  • Fig. 37 Canada Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 38 Key Country Dynamics
  • Fig. 39 Mexico Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 40 Europe Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 41 Key Country Dynamics
  • Fig. 42 UK Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 Germany Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 France Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Italy Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Spain Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 Denmark Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 Sweden Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 55 Norway Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (USD million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Asia Pacific Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 China Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Japan Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 India Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Australia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 South Korea Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Thailand Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Indonesia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Malaysia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Vietnam Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Latin America Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Brazil Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 Argentina Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 Colombia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 Chile Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 MEA Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 South Africa Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Saudi Arabia Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 UAE Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Kuwait Drug Eluting Stents Market Estimates and Forecast, 2021 - 2033 (Revenue in USD Million; Unit Volume in Thousand Units)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Key company categorization
  • Fig. 98 Heat map analysis 2025